0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Please Wait... Processing your request... Please Wait.

Not a subscriber yet?

Each month JAMA Cardiology keeps you up-to-date with the most important advances in the field. Subscribe/Learn More

Current Highlights

Follow Us

Original Investigation | September 21, 2016 FREE ONLINE FIRST

Sex-Specific Cardiac Troponin T Cutoff Values in Myocardial Infarction

This study (the Advantageous Predictors of Acute Coronary Syndrome Evaluation Study) compares the use of a uniform cutoff level with sex-specific cutoff levels of high-sensitivity coronary troponin T in the diagnosis of acute myocardial infarction.

Original Investigation | September 14, 2016 ONLINE FIRST

Cost-effectiveness of Intensive Blood Pressure Management

This cost-effectiveness analysis evaluates the incremental cost-effectiveness of intensive blood pressure management compared with standard management in patients with hypertension.

Original Investigation | September 7, 2016 ONLINE FIRST

Assessing Cardiovascular Risk to Guide Diagnosis and Treatment of Hypertension

This study uses NHANES data to assess the representativeness of the findings of SPRINT and the HOPE-3 trial to US patients and to explore the cardiovascular disease risk profiles of various populations with elevated systolic blood pressure.

Review | August 31, 2016 ONLINE FIRST

Stem Cell Regenerative Therapy for Cardiovascular Disease

This review discusses barriers to the clinical implementation of stem cell therapy in patients with cardiovascular disease as well as potential strategies to overcome them.

Review | August 24, 2016 ONLINE FIRST

Review of Stem Cell Therapy for Heart Failure

This narrative review summarizes published evidence about the effects of stem cell therapy for treatment of patients with ischemic and non-ischemic cardiomyopathies.

Explore more articles:  Current Issue | Online First

Multimedia >

Author Interview

Author photo

Elizabeth M. McNally, MD, PhD interviews Taulant Muka, MD, MSc, DSc, author of Association of Age at Onset of Menopause and Time Since Onset of Menopause With Cardiovascular Outcomes, Intermediate Vascular Traits, and All-Cause Mortality, JoAnn E. Manson, MD, DrPH and Teresa K. Woodruff, PhD, authors of Reproductive Health as a Marker of Subsequent Cardiovascular Disease

audio player

RELATED ARTICLE:

Association of Age at Onset of Menopause and Time Since Onset of Menopause With Cardiovascular Outcomes, Intermediate Vascular Traits, and All-Cause Mortality A Systematic Review and Meta-analysis

All Author Interviews >

Article Video

Video thumbnail

Transesophageal Echocardiography Before Cardiorespiratory Failure (0:12)

Left ventricular contractility was normal prior to cardiorespiratory failure.


All Article Videos >

Author Readings
Author photo

audio player

RELATED ARTICLE:


Physician Jobs